Top Story

NCI director to step down March 31

March 5, 2015

Harold Varmus, MD, who has served as director of the NCI for the past 5 years, will step down at the end of this month.

“I take this step with a mixture of regret and anticipation,” Varmus wrote in a letter to his NCI colleagues. “Regret, because I will miss this job and my working relationships with so many dedicated and talented people. Anticipation, because I look forward to new opportunities to pursue scientific work in the city, New York, that I continue to call home.”

Zhiyuan Zheng, PhD In the Journals

Despite clinical success, laparoscopic colectomy underused in colon cancer treatment

March 5, 2015
Laparoscopic colectomy has shown superiority in clinical trials to open colectomy, but most physicians still choose open resection as the standard of surgical care for…

SCOTUS hears arguments over tax credits for subsidies under ACA

March 4, 2015
The U.S. Supreme Court today began hearing oral arguments in King vs. Burwell, a case that will determine whether the Internal Revenue Service may extend tax-credit…

Bortezomib-based therapy improves outcomes, increases toxicity in mantle cell lymphoma

March 4, 2015
The substitution of bortezomib for vincristine in front-line therapy for mantle cell lymphoma was associated with prolonged PFS and higher response rates, according to…
Meeting News Coverage

Common goals, barriers to antimicrobial stewardship among pediatric cancer patients identified

March 4, 2015
MEMPHIS, Tenn. — Doctors and pharmacists involved in antimicrobial stewardship programs among pediatric cancer patients identified shared program-related goals as…
More News Headlines »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Video
thumbnail for video 4040847621001

MET targeting, PD-L1/PD-1 inhibition highlight recent developments in genitourinary oncology

February 11, 2015
Derek Raghavan, MD, PhD, FACP, FRACP, FASCO, president of Levine Cancer Institute at Carolinas HealthCare System and…
More »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan
morganatic-roan